HealthJun 05, 2026

Imunon raises $10.0M (Jun 2026)

$10.0M
10 Million Dollars
Generated social card
Imunon social card
Headline

Imunon Secures 10 Million Dollars Funding for Ovarian Cancer Trial - HarianBasis.co

About

Imunon is a biotechnology company focused on developing innovative therapies for cancer treatment. The company is currently conducting a trial for ovarian cancer, which is a significant area of need in oncology. This funding will support their efforts to advance their clinical programs.

Article summary

Imunon Secures 10 Million Dollars Funding for Ovarian Cancer Trial  HarianBasis.co

Investors
Related rounds
Jun 22, 2026Ovum$4.0MSeednull
Jun 22, 2026ChemT Biotechnology$4.0MSeedSingapore
Jun 22, 2026ChemT$5.0M—Singapore
Jun 21, 2026Syntax Bio$14.4MSeries AUnited States
Imunon raises $10.0M (June 2026) | Datapile